MINGLIP-50 TABLETS belongs to a class of anti-diabetic drugs called 'dipeptidyl peptidase 4 (DPP-4)' inhibitors used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone. MINGLIP-50 TABLETS may be used alone or in combination with other medicines. Type 2 diabetes is a chronic (long-lasting) condition that affects the way our body processes glucose. People with type 2 diabetes either do not produce enough insulin or cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, which is also known as adult-onset diabetes.

MINGLIP-50 TABLETS contains Vildagliptin which works by preventing the breakdown of a chemical messenger called the 'incretin' hormone. This hormone is released after the meal to stimulate the release of insulin from the pancreas. MINGLIP-50 TABLETS increases the level of 'incretin' hormone so that sufficient insulin can be produced from the pancreas to lower raised blood sugar levels. Thus, MINGLIP-50 TABLETS helps in controlling blood sugar levels in type 2 diabetes mellitus. 

Take MINGLIP-50 TABLETS as prescribed. Your doctor will advise you how often you take MINGLIP-50 TABLETS based on your medical condition. You may experience dizziness, nausea, headache, excessive sweating, low blood sugar levels, and trembling in some cases. Most of these side effects of MINGLIP-50 TABLETS do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to MINGLIP-50 TABLETS or any other medicines, please tell your doctor. MINGLIP-50 TABLETS is not recommended for children below 18 years of age. If you are pregnant or breastfeeding, or are on dialysis, please inform your doctor before taking MINGLIP-50 TABLETS . Avoid alcohol consumption with MINGLIP-50 TABLETS as it may increase or decrease blood sugar levels. MINGLIP-50 TABLETS is not recommended for patients with diabetic ketoacidosis and type-1 diabetes. If you have type 1 diabetes, diabetic ketoacidosis (excessive levels of blood acids called ketones),  or disease of pancreas, kidney, liver, or heart problems, inform your doctor before taking MINGLIP-50 TABLETS .

MINGLIP-50 TABLETS contains Vildagliptin, an anti-diabetic drug used to treat type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone. MINGLIP-50 TABLETS prevents the breakdown of incretin hormones, namely: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) that control blood sugar levels. Thereby, increases the levels of these two hormones which are released after a meal. MINGLIP-50 TABLETS increases insulin production by the pancreas and decreases glucagon production by the liver. Thus, it helps to control blood sugar levels and prevent further complications due to diabetes. Proper diet and regular exercise along with MINGLIP-50 TABLETS , will give better results.

If you are allergic to MINGLIP-50 TABLETS or any other medicines, please tell your doctor. MINGLIP-50 TABLETS is not recommended for children below 18 years of age. If you are pregnant or breastfeeding, or are on dialysis, please inform your doctor before taking MINGLIP-50 TABLETS . Avoid alcohol consumption with MINGLIP-50 TABLETS as it may increase or decrease blood sugar levels. MINGLIP-50 TABLETS is not recommended for patients with diabetic ketoacidosis and type-1 diabetes. Take short, frequent meals and avoid prolonged fasting when taking MINGLIP-50 TABLETS . Beware of hypoglycemia symptoms (low blood sugar), including sweating, dizziness, palpitations, shivering, intense thirst, dry mouth, dry skin, frequent urination, etc. Whenever you experience any of these symptoms, immediately consume 5-6 candies or 3 glucose biscuits, or 3 teaspoons of honey/sugar, and consult your doctor. Make sure to carry these with you at all times, especially during long travels. If you have type 1 diabetes, diabetic ketoacidosis (excessive levels of blood acids called ketones),  or disease of pancreas, kidney, liver, or heart problems, inform your doctor before taking MINGLIP-50 TABLETS . 

Liver function tests are recommended before starting treatment with MINGLIP-50 TABLETS , at 3 months intervals for the first year and at regular intervals thereafter to monitor the signs of increased liver enzymes.